VectivBio
VECT
$16.85
Share price
0.00%
Change (1 day)
206.92%
Change (1 year)
Categories
VectivBio (VECT) - Net assets
Net assets on the balance sheet as of December 2022 : $0.21 B
According to VectivBio's latest financial reports the company has $0.21 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
VectivBio - Net assets on balance sheet (from 2020 to 2022)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2022-12-31 | $0.21 B | 83.94% |
| 2021-12-31 | $0.11 B | 259.82% |
| 2020-12-31 | $32.23 M | 248.07% |
| 2019-12-31 | $9.26 M | -17.62% |
| 2018-12-31 | $11.24 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $6.18 M | -97.10% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $80.25 M | -62.39% | 🇬🇧 UK |
 Novavax NVAX | -$0.72 B | -436.00% | 🇺🇸 USA |
 Novocure
NVCR | $0.36 B | 69.89% | Jersey |